About The Study: This study found an increasing trend in psychotropic medication dispensation among Swedish children and adolescents with type 1 diabetes from 2006 to 2019, persistently higher than those without type 1 diabetes. These findings call for further in-depth investigations into the benefits and risks of psychotropic medications within this population and highlight the importance of integrating pediatric diabetes care and mental health care for early detection of psychological needs and careful monitoring of medication use.
Authors: Shengxin Liu, M.Sc., of the Karolinska Institutet in Solna, Sweden is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi: 10.1001/jamanetworkopen.2023.36621)
